RGEN Repligen Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: RGEN

Price (delayed)

$166.6

Market cap

$10.65B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.2

Enterprise value

$10.61B

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: 8
Relative Profitability: Rel. Profitability: 32

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are ...

Highlights
RGEN's gross profit is up by 34% YoY and by 2.5% QoQ
RGEN's quick ratio is up by 18% year-on-year and by 11% since the previous quarter
The company's net income has shrunk by 128% QoQ
RGEN's EPS has dropped by 127% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.repligen.com
Peers: NVAX BMRN NBIX GE

Key stats

What are the main financial stats of RGEN

RGEN stock price

How has the Repligen stock price performed over time
Intraday
-3.49%
1 week
-1.12%
1 month
-3.43%
1 year
5.44%
YTD
1.67%
QTD
-13.33%

Financial performance

How have Repligen's revenue and profit performed over time
Revenue
$805.61M
Gross profit
$433.14M
Operating income
$18.18M
Net income
-$11.8M
Gross margin
53.8%
Net margin
-1.5%
The net margin has plunged by 128% from the previous quarter
The company's net income has shrunk by 128% QoQ
The operating margin has plunged by 71% from the previous quarter
The operating income has plunged by 70% from the previous quarter

Price vs fundamentals

How does RGEN's price correlate with its fundamentals

Growth

What is Repligen's growth rate over time

Valuation

What is Repligen stock price valuation
RGEN P/E details
P/E
N/A
P/B
4.49
P/S
11.7
EV/EBIT
346.01
EV/EBITDA
83.32
EV/Sales
13.18
RGEN's EPS has dropped by 127% since the previous quarter
The P/B is 14% more than the last 4 quarters average of 4.1
The revenue has grown by 14% YoY and by 2.6% from the previous quarter
RGEN's P/S is 9% above its last 4 quarters average of 11.1 but 5% below its 5-year quarterly average of 12.8

Efficiency

How efficient is Repligen business performance
The return on equity has dropped by 130% since the previous quarter
RGEN's ROA has dropped by 129% since the previous quarter
RGEN's return on sales has dropped by 60% since the previous quarter but it is up by 2.7% year-on-year
The ROIC has plunged by 59% from the previous quarter

Dividends

What is RGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RGEN.

Financial health

How did Repligen financials performed over time
Repligen's current ratio has increased by 18% YoY and by 9% QoQ
RGEN's quick ratio is up by 18% year-on-year and by 11% since the previous quarter
The debt is 67% less than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.